89 related articles for article (PubMed ID: 9002467)
1. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process.
Ruchatz F; Kleinebudde P; Muller BW
J Pharm Sci; 1997 Jan; 86(1):101-5. PubMed ID: 9002467
[TBL] [Abstract][Full Text] [Related]
2. Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process.
Bleich J; Müller BW
J Microencapsul; 1996; 13(2):131-9. PubMed ID: 8999119
[TBL] [Abstract][Full Text] [Related]
3. Application of aerosol solvent extraction system (ASES) process for preparation of liposomes in a dry and reconstitutable form.
Kunastitchai S; Pichert L; Sarisuta N; Müller BW
Int J Pharm; 2006 Jun; 316(1-2):93-101. PubMed ID: 16621359
[TBL] [Abstract][Full Text] [Related]
4. Drug solubility in phospholipid carrier as a predictive parameter for drug recovery in microparticles produced by the aerosol solvent extraction system (ASES) process.
Sarisuta N; Kunastitchai S; Pichert L; Müller BW
Drug Dev Ind Pharm; 2007 Sep; 33(9):932-44. PubMed ID: 17891579
[TBL] [Abstract][Full Text] [Related]
5. Size controlled production of biodegradable microparticles with supercritical gases.
Thies J; Müller BW
Eur J Pharm Biopharm; 1998 Jan; 45(1):67-74. PubMed ID: 9689537
[TBL] [Abstract][Full Text] [Related]
6. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery.
Steckel H; Pichert L; Müller BW
Eur J Pharm Biopharm; 2004 May; 57(3):507-12. PubMed ID: 15093600
[TBL] [Abstract][Full Text] [Related]
7. Carbon dioxide extraction of residual solvents in poly(lactide-co-glycolide) microparticles.
Herberger J; Murphy K; Munyakazi L; Cordia J; Westhaus E
J Control Release; 2003 Jun; 90(2):181-95. PubMed ID: 12810301
[TBL] [Abstract][Full Text] [Related]
8. Prednisolone multicomponent nanoparticle preparation by aerosol solvent extraction system.
Moribe K; Fukino M; Tozuka Y; Higashi K; Yamamoto K
Int J Pharm; 2009 Oct; 380(1-2):201-5. PubMed ID: 19576974
[TBL] [Abstract][Full Text] [Related]
9. Microparticle formation and its mechanism in single and double emulsion solvent evaporation.
Rosca ID; Watari F; Uo M
J Control Release; 2004 Sep; 99(2):271-80. PubMed ID: 15380636
[TBL] [Abstract][Full Text] [Related]
10. Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process.
Koushik K; Kompella UB
Pharm Res; 2004 Mar; 21(3):524-35. PubMed ID: 15070105
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable semi-crystalline comb polyesters influence the microsphere production by means of a supercritical fluid extraction technique (ASES).
Breitenbach A; Mohr D; Kissel T
J Control Release; 2000 Jan; 63(1-2):53-68. PubMed ID: 10640580
[TBL] [Abstract][Full Text] [Related]
12. Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles.
Falk RF; Randolph TW
Pharm Res; 1998 Aug; 15(8):1233-7. PubMed ID: 9706054
[TBL] [Abstract][Full Text] [Related]
13. Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.
Patomchaiviwat V; Paeratakul O; Kulvanich P
AAPS PharmSciTech; 2008; 9(4):1119-29. PubMed ID: 18989787
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable microparticles for delivery of polypeptides and proteins.
Spenlehauer G; Spenlehauer-Bonthonneau F; Thies C
Prog Clin Biol Res; 1989; 292():283-91. PubMed ID: 2726909
[TBL] [Abstract][Full Text] [Related]
15. Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.
Bustami RT; Chan HK; Sweeney T; Dehghani F; Foster NR
Pharm Res; 2003 Dec; 20(12):2028-35. PubMed ID: 14725370
[TBL] [Abstract][Full Text] [Related]
16. Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide.
Bustami RT; Chan HK; Dehghani F; Foster NR
Pharm Res; 2000 Nov; 17(11):1360-6. PubMed ID: 11205728
[TBL] [Abstract][Full Text] [Related]
17. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
Du Z; Guan YX; Yao SJ; Zhu ZQ
Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
[TBL] [Abstract][Full Text] [Related]
19. Preparation of cefpodoxime proxetil fine particles using supercritical fluids.
Chu J; Li G; Row KH; Kim H; Lee YW
Int J Pharm; 2009 Mar; 369(1-2):85-91. PubMed ID: 19041383
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication.
Katou H; Wandrey AJ; Gander B
Int J Pharm; 2008 Nov; 364(1):45-53. PubMed ID: 18782610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
